← Back to Search

Chronic Sinusitis for Chronic Sinusitis

N/A
Recruiting
Research Sponsored by Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

A Case control study with 150 cases and 50 controls will be conducted. Immunologic (cytokines measurements in nasal secretions and sinonasal tissues), histopathologic (tissue eosinophilia) and clinical parameters (Lund-Mackay and Lund-Kennedy score, lung function tests), surveys (SNOT- 22, SF-36 quality of life survey) will be compared between different groups of patients

Eligible Conditions
  • Chronic Sinusitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Endotypic markers
Secondary outcome measures
SF-36
SNOT-22

Trial Design

2Treatment groups
Experimental Treatment
Group I: ControlsExperimental Treatment1 Intervention
Group II: Chronic SinusitisExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

GlaxoSmithKlineIndustry Sponsor
4,750 Previous Clinical Trials
8,067,252 Total Patients Enrolled
1 Trials studying Chronic Sinusitis
8 Patients Enrolled for Chronic Sinusitis
Thomas Jefferson UniversityLead Sponsor
444 Previous Clinical Trials
145,424 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~133 spots leftby Jan 2026